{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:18:57Z","timestamp":1761311937523,"version":"3.44.0"},"reference-count":22,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>Cushing\u2019s syndrome (CS) due to ectopic adrenocorticotropic hormone (ACTH) secretion (EAS) can result from a variety of tumours and rarely from those of prostatic origin. We present a male patient in his early 60s with ACTH-secreting metastatic prostate adenocarcinoma with neuroendocrine differentiation (ICD-O code 8574\/3) years after prostatectomy and androgen-deprivation therapy, initially presenting with Cushingoid features. After open radical prostatectomy and bilateral orchiectomy for disease recurrence, the patient was found to have metastatic liver and bone lesions highly suggestive of metastatic prostatic cancer. About 10% of cells on liver biopsy expressed ACTH, a finding consistent with EAS as the cause of CS. His stay was complicated with multiple infections and ultimate death. Hence, we report a case of metastatic prostate adenocarcinoma with neuroendocrine differentiation who presented with CS. We also emphasize the importance of adequate and timely treatment.<\/jats:p>","DOI":"10.1136\/bcr-2021-247997","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T11:16:37Z","timestamp":1671448597000},"page":"e247997","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["ACTH-secreting metastatic prostate cancer with neuroendocrine differentiation"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-8740","authenticated-orcid":false,"given":"Bashar","family":"Hassan","sequence":"first","affiliation":[{"name":"Faculty of Medicine, American University of Beirut, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"Yazbeck","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Akiki","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Salti","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arafat","family":"Tfayli","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"2025082800052737000_15.12.e247997.1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2527"},{"key":"2025082800052737000_15.12.e247997.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.1994.tb02150.x"},{"key":"2025082800052737000_15.12.e247997.3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870515)59:10<1803::AID-CNCR2820591019>3.0.CO;2-X"},{"key":"2025082800052737000_15.12.e247997.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1542"},{"key":"2025082800052737000_15.12.e247997.5","unstructured":"Rosario E , Rosario DJ . Localized Prostate Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 20202020."},{"key":"2025082800052737000_15.12.e247997.6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840915)54:6<1043::AID-CNCR2820540619>3.0.CO;2-U"},{"key":"2025082800052737000_15.12.e247997.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)80134-7"},{"key":"2025082800052737000_15.12.e247997.8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0100-z"},{"key":"2025082800052737000_15.12.e247997.9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4158\/EP09243.CR","article-title":"Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer","volume":"16","author":"Alshaikh","year":"2010","journal-title":"Endocr Pract"},{"key":"2025082800052737000_15.12.e247997.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.21"},{"key":"2025082800052737000_15.12.e247997.11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/imj.13063","article-title":"Ectopic Cushing syndrome due to neuroendocrine prostatic cancer","volume":"46","author":"Shrosbree","year":"2016","journal-title":"Intern Med J"},{"key":"2025082800052737000_15.12.e247997.12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/iju.13225","article-title":"Treatment-Related neuroendocrine prostate cancer resulting in Cushing's syndrome","volume":"23","author":"Ramalingam","year":"2016","journal-title":"Int J Urol"},{"key":"2025082800052737000_15.12.e247997.13","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0081"},{"key":"2025082800052737000_15.12.e247997.14","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.clgc.2018.09.002","article-title":"Paraneoplastic syndrome secondary to treatment emergent neuroendocrine tumor in metastatic castration-resistant prostate cancer: a unique case","volume":"17","author":"Murphy","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"2025082800052737000_15.12.e247997.15","first-page":"e192","article-title":"Ectopic adrenocorticotropic hormone syndrome due to metastatic prostate cancer with neuroendocrine differentiation","volume":"5","author":"Soundarrajan","year":"2019","journal-title":"AACE Clin Case Rep"},{"key":"2025082800052737000_15.12.e247997.16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00090"},{"key":"2025082800052737000_15.12.e247997.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2004.01930.x"},{"key":"2025082800052737000_15.12.e247997.18","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.047829"},{"key":"2025082800052737000_15.12.e247997.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028"},{"key":"2025082800052737000_15.12.e247997.20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3233\/CBM-2011-0198","article-title":"Plasma chromogranin A: clinical implications in patients with castrate resistant prostate cancer receiving docetaxel chemotherapy","volume":"8","author":"Sarkar","journal-title":"Cancer Biomark"},{"key":"2025082800052737000_15.12.e247997.21","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3892\/mco.2015.645","article-title":"Neuroendocrine differentiation in castration-resistant prostate cancer: a case report","volume":"3","author":"Priftakis","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"2025082800052737000_15.12.e247997.22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0877"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-247997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:05:32Z","timestamp":1756364732000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-247997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,19]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/bcr-2021-247997"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-247997","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}